Annual EBITDA
-$493.48M$36.80M-8.06%
Summary
- Current Value
- As of today, CYTK annual EBITDA is -$493.48M, down -8.06% on
- Historical Performance
- CYTK annual EBITDA is down -168.63% over the past 3 years, and down -430.40% over the past 5 years
- All-Time High Comparison
- CYTK annual EBITDA is currently -1919.36% below its historical high of $27.12M set on
- 3-Year Low Comparison
- CYTK annual EBITDA is at its 3-year low
- Sector Comparison
- CYTK annual EBITDA is higher than 1.61% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$493.48M | -8.1% | -168.6% | -430.4% | -1919.4% | |
| Quarterly EBITDA | -$164.08M | -18.6% | -54.3% | -2968.5% | -1256.7% | |
| TTM EBITDA | -$563.29M | -10.2% | -167.6% | -608.6% | -1062.1% | |
| Price | $64.60 | +33.2% | +49.7% | +200.1% | +422.6% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $18.47M | +145.3% | -73.8% | -31.2% | -77.3% | |
| Annual EPS | -$5.26 | +3.4% | -88.0% | -149.1% | -308.9% | |
| Annual EBIT | -$503.01M | -7.3% | -170.5% | -433.2% | -2103.8% | |
| Annual Net Income | -$589.53M | -12.0% | -173.8% | -384.4% | -2501.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$331.99M | N/A | -48.6% |
| 5Y | -$86.78M | N/A | -468.6% |
| All | $27.12M | -1919.4% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$493.48M | at low | |
| 5Y | -$493.48M | at low | |
| All | -$493.48M | at low |
EBITDA History
FAQ
What is the current annual EBITDA of CYTK?
As of today, CYTK annual EBITDA is -$493.48M
What is 1-year change in CYTK annual EBITDA?
CYTK annual EBITDA is down -8.06% year-over-year
What is 3-year change in CYTK annual EBITDA?
CYTK annual EBITDA is down -168.63% over the past 3 years
How far is CYTK annual EBITDA from its all-time high?
CYTK annual EBITDA is currently -1919.36% below its historical high of $27.12M set on December 31, 2009
How does CYTK annual EBITDA rank versus sector peers?
CYTK annual EBITDA is higher than 1.61% of companies in Healthcare sector
When is CYTK next annual earnings release?
The next annual earnings release for CYTK is on
Quarterly EBITDA
-$164.08M$54.86M-50.22%
Summary
- Current Value
- As of today, CYTK quarterly EBITDA is -$164.08M, down -50.22% on
- Historical Performance
- CYTK quarterly EBITDA is down -18.56% year-over-year, and down -54.27% over the past 3 years
- All-Time High Comparison
- CYTK quarterly EBITDA is currently -382.34% below its historical high of $58.11M set on
- 3-Year Low Comparison
- CYTK quarterly EBITDA is at its 3-year low
- Sector Comparison
- CYTK quarterly EBITDA is higher than 1.17% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$164.08M | -50.2% | -18.6% | -54.3% | -2968.5% | |
| Annual EBITDA | -$493.48M | – | -8.1% | -168.6% | -430.4% | |
| TTM EBITDA | -$563.29M | -4.8% | -10.2% | -167.6% | -608.6% | |
| Price | $64.60 | +7.4% | +33.2% | +49.7% | +200.1% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $1.94M | -97.1% | +318.1% | -23.0% | -95.4% | |
| Quarterly EPS | -$2.55 | -126.9% | -87.1% | -68.1% | -5388.0% | |
| Quarterly EBIT | -$166.76M | -49.5% | -18.4% | -53.8% | -3316.7% | |
| Quarterly Net Income | -$306.18M | -127.9% | -90.7% | -115.2% | -9543.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$109.22M | -50.2% | |
| 3Y | -$109.22M | -50.2% | |
| 5Y | -$8.87M | -1749.4% | |
| All | $58.11M | -382.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$164.08M | at low | |
| 3Y | -$164.08M | at low | |
| 5Y | -$164.08M | at low | |
| All | -$164.08M | at low |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of CYTK?
As of today, CYTK quarterly EBITDA is -$164.08M
What is CYTK quarterly EBITDA most recent change?
CYTK quarterly EBITDA was down -50.22% on September 30, 2025
What is 1-year change in CYTK quarterly EBITDA?
CYTK quarterly EBITDA is down -18.56% year-over-year
How far is CYTK quarterly EBITDA from its all-time high?
CYTK quarterly EBITDA is currently -382.34% below its historical high of $58.11M set on June 30, 2009
How does CYTK quarterly EBITDA rank versus sector peers?
CYTK quarterly EBITDA is higher than 1.17% of companies in Healthcare sector
When is CYTK next earnings release?
The next earnings release for CYTK is on
TTM EBITDA
-$563.29M$25.69M-4.78%
Summary
- Current Value
- As of today, CYTK TTM EBITDA is -$563.29M, down -4.78% on
- Historical Performance
- CYTK TTM EBITDA is down -10.20% year-over-year, and down -167.56% over the past 3 years
- All-Time High Comparison
- CYTK TTM EBITDA is currently -2015.87% below its historical high of $29.40M set on
- 3-Year Low Comparison
- CYTK TTM EBITDA is at its 3-year low
- Sector Comparison
- CYTK TTM EBITDA is higher than 1.08% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$563.29M | -4.8% | -10.2% | -167.6% | -608.6% | |
| Annual EBITDA | -$493.48M | – | -8.1% | -168.6% | -430.4% | |
| Quarterly EBITDA | -$164.08M | -50.2% | -18.6% | -54.3% | -2968.5% | |
| Price | $64.60 | +7.4% | +33.2% | +49.7% | +200.1% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $87.21M | +1.7% | +2609.3% | -41.2% | +60.6% | |
| TTM EPS | -$6.31 | -23.2% | -17.1% | -99.3% | -229.7% | |
| TTM EBIT | -$572.93M | -4.7% | -9.2% | -161.8% | -605.2% | |
| TTM Net Income | -$751.94M | -24.0% | -30.4% | -166.5% | -559.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$526.72M | N/A | -6.9% |
| 3Y | -$315.80M | N/A | -78.4% |
| 5Y | -$92.11M | N/A | -511.5% |
| All | $29.40M | -2015.9% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$563.29M | at low | |
| 3Y | -$563.29M | at low | |
| 5Y | -$563.29M | at low | |
| All | -$563.29M | at low |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of CYTK?
As of today, CYTK TTM EBITDA is -$563.29M
What is CYTK TTM EBITDA most recent change?
CYTK TTM EBITDA was down -4.78% on September 30, 2025
What is 1-year change in CYTK TTM EBITDA?
CYTK TTM EBITDA is down -10.20% year-over-year
How far is CYTK TTM EBITDA from its all-time high?
CYTK TTM EBITDA is currently -2015.87% below its historical high of $29.40M set on September 30, 2009
How does CYTK TTM EBITDA rank versus sector peers?
CYTK TTM EBITDA is higher than 1.08% of companies in Healthcare sector
When is CYTK next earnings release?
The next earnings release for CYTK is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- CYTK Official Website www.cytokinetics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1061983/000119312525267059/0001193125-25-267059-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1061983/000095017025029206/0000950170-25-029206-index.htm
- CYTK Profile on Yahoo Finance finance.yahoo.com/quote/CYTK
- CYTK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cytk